- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩3.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩375,500.00
7D
10.0%
1Y
-33.8%
Samsung BiologicsLtd
Market Cap: ₩71.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,549,000.00
7D
11.0%
1Y
-7.4%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,250.00
7D
0.3%
1Y
-5.6%
JW Shinyak
Market Cap: ₩94.5b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,691.00
7D
-21.2%
1Y
10.1%
JW Holdings
Market Cap: ₩257.0b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,715.00
7D
-2.6%
1Y
4.4%
SK Biopharmaceuticals
Market Cap: ₩6.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩78,300.00
7D
0.9%
1Y
-22.4%